Avapro and Cozaar are now the first drugs APPROVED for kidney disease in patients with type 2 diabetes and hypertension

October 2002

Avapro and Cozaar are now the first drugs APPROVED for kidney disease in patients with type 2 diabetes and hypertension.

For years ACE inhibitors were preferred for these patients. But no ACE inhibitor is actually APPROVED for this use.

Avapro (irbesartan) and Cozaar (losartan) slow progression of kidney disease...similar to ACE inhibitors. Other angiotensin receptor blockers probably work too.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote